Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Gombos, A.; Goncalves, A.; Curigliano, G.; Bartsch, R.;
Kyte, Jon A
; Ignatiadis, M.; Awada, A.
(2023).
How I treat endocrine-dependent metastatic breast cancer.
ESMO Open.
Vol. 8.
https://doi.org/10.1016/j.esmoop.2023.100882
Westgaard, Arne;
Kyte, Jon A
; Gjersvik, Petter
(2023).
Genforandringer som egner seg for målrettet kreftbehandling.
Tidsskrift for Den norske legeforening.
https://doi.org/10.4045/TIDSSKR.23.0076
Beck, Carole Anne; Casey, Nicholas Paul; Persiconi, Irene; Nejati Moharrami, Neda; Sike, Adam; Jin, Yixin;
Kyte, Jon A
(2023).
Development of a TGFβ—IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy.
Biomedicines.
Vol. 11.
https://doi.org/10.3390/biomedicines11020459
Røssevold, Andreas Hagen; Andresen, Nikolai Kragøe; Bjerre, Christina Annette; Gilje, Bjørnar; Jakobsen, Erik Hugger; Raj, Sunil Xavier; Falk, Ragnhild Sørum; Russnes, Hege Elisabeth Giercksky; Jahr, Thea; Ruud, Randi Margit; Lømo, Jon; Garred, Øystein; Chauhan, Sudhir Kumar; Lereim, Ragnhild Reehorst; Dunn, Claire; Naume, Bjørn;
Kyte, Jon A
(2022).
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Nature Medicine.
https://doi.org/10.1038/s41591-022-02126-1
Aamdal, Elin; Skovlund, Eva; Jacobsen, Kari Dolven; Straume, Oddbjørn; Kersten, Christian; Herlofsen, Oluf; Karlsen, Jarle; Hussain, Israr; Amundsen, Anita; Dalhaug, Astrid; Nyakas, Marta Sølvi; Hagene, Kirsten Thorin; Holmsen, Kjersti; Aamdal, Steinar; Kaasa, Stein; Guren, Tormod Kyrre;
Kyte, Jon A
(2022).
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment.
ESMO Open.
Vol. 7.
https://doi.org/10.1016/j.esmoop.2022.100588
Jin, Yixin; Lorvik, Kristina Berg; Jin, Yang; Beck, Carole; Sike, Adam; Persiconi, Irene; Kvaløy, Emilie; Saatcioglu, Fahri; Dunn, Claire;
Kyte, Jon A
(2022).
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
17 s.
Molecular Therapy - Oncolytics.
Vol. 26.
https://doi.org/10.1016/j.omto.2022.06.007
Dorraji, Seyed Esmaeil; Borgen, Elin; Segura-Pena, Dario; Rawat, Puneet; Smorodina, Eva; Dunn, Claire; Greiff, Victor; Sekulic, Nikolina; Russnes, Hege Elisabeth Giercksky;
Kyte, Jon A
(2022).
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.
Cancers.
Vol. 14:4859.
https://doi.org/10.3390/cancers14194859
Kyte, Jon A
(2022).
Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers.
Cancers.
Vol. 14.
https://doi.org/10.3390/cancers14030571
Aamdal, Elin; Jacobsen, Kari Dolven; Straume, Oddbjørn; Kersten, Christian; Herlofsen, Oluf; Karlsen, Jarle; Hussain, Israr; Amundsen, Anita; Dalhaug, Astrid; Nyakas, Marta Sølvi; Schuster, Cornelia; Hagene, Kirsten Thorin; Holmsen, Kjersti; Russnes, Hege Elisabeth Giercksky; Skovlund, Eva; Kaasa, Stein; Aamdal, Steinar;
Kyte, Jon A.
; Guren, Tormod Kyrre
(2021).
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.
International Journal of Cancer.
Vol. 150.
https://doi.org/10.1002/ijc.33768
Brunsvig, Paal Fr.; Guren, Tormod Kyrre; Nyakas, Marta Sølvi; Reisse, Claudius; Rasch, Wenche;
Kyte, Jon A
; Juul, Hedvig Vidarsdotter; Aamdal, Steinar; Gaudernack, Gustav; Inderberg, Else Marit
(2020).
Long-term outcomes of a phase I study with UV1, a second generation telomerase based vaccine, in patients with advanced non-small cell lung cancer.
Frontiers in Immunology.
Vol. 11:572172.
https://doi.org/10.3389/fimmu.2020.572172
